|
CRLS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62636570877339E-12 |
| Normal-vs-Stage2 |
2.856900E-03 |
| Normal-vs-Stage3 |
1.056180E-02 |
| Normal-vs-Stage4 |
2.380200E-01 |
| Stage1-vs-Stage2 |
7.651200E-01 |
| Stage1-vs-Stage3 |
6.010000E-02 |
| Stage1-vs-Stage4 |
7.82719999999903E-05 |
| Stage2-vs-Stage3 |
2.128200E-01 |
| Stage2-vs-Stage4 |
2.064200E-02 |
| Stage3-vs-Stage4 |
1.516590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
8.13730000048807E-07 |
| Normal-vs-Asian |
4.363000E-01 |
| Caucasian-vs-AfricanAmerican |
1.444410E-01 |
| Caucasian-vs-Asian |
1.404000E-01 |
| AfricanAmerican-vs-Asian |
2.576600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
4.7467999975126E-08 |
| Male-vs-Female |
4.166100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.37669999999724E-05 |
| Normal-vs-Extreme_Weight |
1.35400024525723E-10 |
| Normal-vs-Obese |
6.15689998983981E-09 |
| Normal-vs-Extreme_Obese |
1.480190E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.511750E-02 |
| Normal_Weight-vs-Obese |
4.795100E-03 |
| Normal_Weight-vs-Extreme_Obese |
9.188000E-01 |
| Extreme_Weight-vs-Obese |
4.514400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.067000E-01 |
| Obese-vs-Extreme_Obese |
2.044200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.009660E-02 |
| Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
| Normal-vs-Age(61-80Yrs) |
1.75914838251856E-12 |
| Normal-vs-Age(81-100Yrs) |
9.541500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.021800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.252800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.950410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.641700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.764800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.999240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.556500E-02 |
| Normal-VS-KIRP CIMP |
1.757240E-01 |
| Normal-VS-Unclassified PRCC |
3.92909999999969E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.62592161956354E-12 |
| Type1 PRCC-VS-KIRP CIMP |
5.44708722571841E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
4.164800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.153800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.014000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
2.809000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.048400E-04 |
| Normal-vs-N1 |
4.056000E-03 |
| Normal-vs-N2 |
3.498600E-01 |
| N0-vs-N1 |
9.590400E-01 |
| N0-vs-N2 |
9.461200E-01 |
| N1-vs-N2 |
9.581400E-01 |
|
|
